AI and machine learning technology business InferSens has welcomed Her Excellency the Honourable Dr Jeannette Young AC PSM, Governor of Queensland to its new headquarters at the St John’s Innovation Centre in Cambridge, UK.
InferSens currently applies its expertise in tinyML – an emerging branch of machine learning that shrinks deep learning networks to fit on tiny, low powered hardware – to simplify and automate Legionella risk monitoring in properties.
The purpose of the Governor’s visit is to focus on innovative and leading start-ups in Cambridge, Europe’s largest technology cluster.
Her Excellency the Honourable Dr Jeannette Young AC PSM, said: “We are delighted to have visited InferSens in Cambridge to discover their ground-breaking work in artificial intelligence and machine learning enabled water flow and temperature sensors.”
Colin Payne, CEO of InferSens, added: “We are extremely pleased to have welcomed the Governor of Queensland on an official visit to our new headquarters. It is a great honour for our company.
“InferSens’ first application is around using our technology to automate Legionella risk monitoring, supporting the maintenance of safe water systems, and preventing outbreaks such as Legionnaire’s disease, a global public health concern. The Governor is the former Chief Health Officer of Queensland, and we were therefore delighted to be given the opportunity to explain our application to her.”
InferSens’ non-invasive technology, which involves a small, highly affordable sensor clipped onto a pipe, can generate and monitor real time critical data in relation to the flow and temperature of any liquid. Sensors can be deployed on any sized pipe, including national infrastructures. The ability of the technology to significantly reduce the current costly, and inefficient practices of recurrent manual testing of public facing water infrastructures massively reduces the scope for waste, meaning that it will also greatly contribute to environmental and sustainability improvement achievements by its clients.
In May 2022, RO Capital Partners announced that it had led a major seed investment round in InferSens alongside (amongst others) the Oxford Innovation Fund, and Bruce Melizan, the former MD of Interserve’s support services division to help accelerate the company’s product development and routes to market.